Advertisement
Research Article

Effect of Different Interferonα2 Preparations on IP10 and ET-1 Release from Human Lung Cells

  • Rekha Badiger equal contributor,

    equal contributor Contributed equally to this work with: Rekha Badiger, Jane A. Mitchell

    Affiliation: Cardiothoracic Pharmacology, National Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom

    X
  • Jane A. Mitchell equal contributor mail,

    equal contributor Contributed equally to this work with: Rekha Badiger, Jane A. Mitchell

    j.a.mitchell@imperial.ac.uk

    Affiliation: Cardiothoracic Pharmacology, National Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom

    X
  • Hime Gashaw,

    Affiliation: Cardiothoracic Pharmacology, National Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom

    X
  • Neil A. Galloway-Phillipps,

    Affiliation: Cardiothoracic Pharmacology, National Heart and Lung Institute (NHLI), Imperial College, London, United Kingdom

    X
  • Stefan Foser,

    Affiliation: Hoffmann-La Roche, Basel, Switzerland

    X
  • Fernando Tatsch,

    Affiliation: Hoffmann-La Roche, Basel, Switzerland

    X
  • Thomas Singer,

    Affiliation: Hoffmann-La Roche, Basel, Switzerland

    X
  • Trevor T. Hansel,

    Affiliation: Imperial Clinical Respiratory Research Unit (ICRRU), St. Mary's Hospital, London, United Kingdom

    X
  • Tobias Manigold

    Affiliations: Hoffmann-La Roche, Basel, Switzerland, Department of Internal Medicine, University Hospital, Basel, Switzerland

    X
  • Published: October 08, 2012
  • DOI: 10.1371/journal.pone.0046779

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.